Intuitive Surgical, Inc. (ISRG) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $354.36 (+0.41%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 23, 2026 | Vijay Kumar | Evercore ISI | $550.00 | +55.2% |
| Dec 17, 2025 | Shagun Singh | RBC Capital | $650.00 | +83.4% |
| Oct 22, 2025 | Anthony Petrone | Mizuho Securities | $575.00 | +62.3% |
| Oct 22, 2025 | Richard Newitter | Truist Financial | $620.00 | +75.0% |
| Oct 22, 2025 | Adam Maeder | Piper Sandler | $610.00 | +72.1% |
| Oct 21, 2025 | Lee Hambright | Bernstein | $685.00 | +93.3% |
| Jul 14, 2025 | Ryan Zimmerman | BTIG | $566.00 | +59.7% |
| Apr 14, 2025 | Ryan Zimmerman | BTIG | $560.00 | +58.0% |
| Dec 18, 2024 | Richard Newitter | Truist Financial | $640.00 | +80.6% |
| Dec 2, 2024 | Patrick Wood | Morgan Stanley | $650.00 | +83.4% |
| Oct 18, 2024 | David Roman | Goldman Sachs | $604.00 | +70.4% |
| Oct 18, 2024 | Shagun Singh | RBC Capital | $555.00 | +56.6% |
| Oct 18, 2024 | Adam Maeder | Piper Sandler | $538.00 | +51.8% |
| Oct 18, 2024 | Anthony Petrone | Mizuho Securities | $550.00 | +55.2% |
| Oct 18, 2024 | Rick Wise | Stifel Nicolaus | $525.00 | +48.2% |
| Oct 18, 2024 | Richard Newitter | Truist Financial | $570.00 | +60.9% |
| Oct 18, 2024 | Vijay Kumar | Evercore ISI | $490.00 | +38.3% |
| Oct 18, 2024 | Ryan Zimmerman | BTIG | $535.00 | +51.0% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $565.00 | +59.4% |
| Oct 15, 2024 | Larry Biegelsen | Wells Fargo | $466.00 | +31.5% |
Top Analysts Covering ISRG
ISRG vs Sector & Market
| Metric | ISRG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.25 | 2.42 |
| Analyst Count | 30 | 8 | 19 |
| Target Upside | +38.6% | +16316.1% | +17.1% |
| P/E Ratio | 44.91 | 2.97 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.30B | $11.67B | $12.51B | 24 |
| 2027-03-31 | $3.05B | $3.12B | $3.18B | 11 |
| 2027-06-30 | $3.17B | $3.24B | $3.30B | 8 |
| 2027-09-30 | $3.25B | $3.32B | $3.38B | 8 |
| 2027-12-31 | $3.55B | $3.63B | $3.70B | 15 |
| 2028-03-31 | $3.32B | $3.39B | $3.46B | 10 |
| 2028-06-30 | $3.52B | $3.59B | $3.66B | 7 |
| 2028-09-30 | $3.56B | $3.64B | $3.71B | 7 |
| 2028-12-31 | $3.89B | $3.98B | $4.06B | 14 |
| 2029-12-31 | $16.60B | $17.36B | $18.31B | 11 |
| 2030-12-31 | $18.21B | $19.04B | $20.09B | 11 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $10.05 | $10.31 | $10.46 | 16 |
| 2027-03-31 | $2.64 | $2.72 | $2.79 | 10 |
| 2027-06-30 | $2.78 | $2.86 | $2.93 | 7 |
| 2027-09-30 | $2.87 | $2.96 | $3.03 | 7 |
| 2027-12-31 | $3.13 | $3.21 | $3.30 | 14 |
| 2028-03-31 | $2.78 | $2.86 | $2.94 | 11 |
| 2028-06-30 | $3.04 | $3.13 | $3.21 | 8 |
| 2028-09-30 | $3.11 | $3.19 | $3.28 | 8 |
| 2028-12-31 | $3.39 | $3.49 | $3.58 | 15 |
| 2029-12-31 | $14.46 | $15.33 | $16.43 | 4 |
| 2030-12-31 | $15.89 | $16.83 | $18.04 | 4 |
Frequently Asked Questions
What is the analyst consensus for ISRG?
The consensus among 30 analysts covering Intuitive Surgical, Inc. (ISRG) is Buy with an average price target of $597.78.
What is the highest price target for ISRG?
The highest price target for ISRG is $685.00, set by Lee Hambright at Bernstein on 2025-10-21.
What is the lowest price target for ISRG?
The lowest price target for ISRG is $225.00, set by Imron Zafar at Deutsche Bank on 2022-06-29.
How many analysts cover ISRG?
30 analysts have issued ratings for Intuitive Surgical, Inc. in the past 12 months.
Is ISRG a buy or sell right now?
Based on 30 analyst ratings, ISRG has a consensus rating of Buy (2.17/5) with a +38.6% upside to the consensus target of $597.78.
What are the earnings estimates for ISRG?
Analysts estimate ISRG will report EPS of $10.31 for the period ending 2026-12-31, with revenue estimated at $11.67B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.